These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20727509)

  • 1. Antibiotic pharmacokinetic and pharmacodynamic considerations in patients with kidney disease.
    Eyler RF; Mueller BA
    Adv Chronic Kidney Dis; 2010 Sep; 17(5):392-403. PubMed ID: 20727509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selecting antibiotics based on pharmacokinetic and pharmacodynamic principles.
    Klutman NE
    Pharm Pract Manag Q; 1996 Jul; 16(2):9-12. PubMed ID: 10161616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal antibiotic dosing. The pharmacokinetic-pharmacodynamic interface.
    Reed MD
    Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):17-24. PubMed ID: 19667545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoglycosides in hemodialysis patients: is the current practice of post dialysis dosing appropriate?
    O'Shea S; Duffull S; Johnson DW
    Semin Dial; 2009; 22(3):225-30. PubMed ID: 19386073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective.
    Mouton JW; Ambrose PG; Canton R; Drusano GL; Harbarth S; MacGowan A; Theuretzbacher U; Turnidge J
    Drug Resist Updat; 2011 Apr; 14(2):107-17. PubMed ID: 21440486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monitoring of antibiotic treatment of patient with a severe bacterial infection].
    Aubert G; Carricajo A
    Ann Fr Anesth Reanim; 2004 Jul; 23(7):704-13. PubMed ID: 15324959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics/Pharmacodynamics for critical care clinicians.
    Quintiliani R; Quintiliani R
    Crit Care Clin; 2008 Apr; 24(2):335-48, xi. PubMed ID: 18361949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New recommendations for antibiotic dosing in patients with renal insufficiency and in patients undergoing haemodialysis].
    Moser C; Elung-Jensen T; Høiby N
    Ugeskr Laeger; 2008 Feb; 170(8):629-32. PubMed ID: 18364153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuing education: alternative approaches to optimizing antimicrobial pharmacodynamics in critically ill patients.
    Winterboer TM; Lecci KA; Olsen KM
    J Pharm Pract; 2010 Feb; 23(1):6-18. PubMed ID: 21507788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic factors of antibiotic efficacy.
    Rotschafer JC; Zabinski RA; Walker KJ
    Pharmacotherapy; 1992; 12(6 Pt 2):64S-70S. PubMed ID: 1480502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Pharmacology of Antibiotics.
    Eyler RF; Shvets K
    Clin J Am Soc Nephrol; 2019 Jul; 14(7):1080-1090. PubMed ID: 30862698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of in vitro activity and pharmacokinetic parameters with effect in vivo for antibiotics. Observations from experimental pneumococcus infection.
    Frimodt-Møller N
    Dan Med Bull; 1988 Oct; 35(5):422-37. PubMed ID: 3066588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic issues for antibiotics in the critically ill patient.
    Roberts JA; Lipman J
    Crit Care Med; 2009 Mar; 37(3):840-51; quiz 859. PubMed ID: 19237886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing clinical outcomes by the use of pharmokinetic and pharmacodynamic principles.
    Quintiliani R
    J Med Liban; 2000; 48(4):182-5. PubMed ID: 11214187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine.
    McKellar QA; Sanchez Bruni SF; Jones DG
    J Vet Pharmacol Ther; 2004 Dec; 27(6):503-14. PubMed ID: 15601444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of respiratory tract infections.
    Andes D; Anon J; Jacobs MR; Craig WA
    Clin Lab Med; 2004 Jun; 24(2):477-502. PubMed ID: 15177850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What have we learned from pharmacokinetic and pharmacodynamic theories?
    Schentag JJ; Gilliland KK; Paladino JA
    Clin Infect Dis; 2001 Mar; 32 Suppl 1():S39-46. PubMed ID: 11249828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical implications of antibiotic pharmacokinetic-pharmacodynamic parameters].
    Cohen R
    Arch Pediatr; 2008 Oct; 15 Suppl 2():S53-8. PubMed ID: 19000855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.